Terminated PHASE2 INTERVENTIONAL 11-arm NCT00312286

Efficacy of 851B Gel for Treating High-Risk Cervical Human Papillomavirus Infection in Women.

A Randomized, Placebo-Controlled Phase II Study of Multiple Dosing Regimens of Intravaginally Administered 851B Gel for the Treatment of Cervical High Risk HPV Infection

Sponsor: Takeda

Conditions Papillomavirus Infections

Interventions 851B

Updated 8 times since 2017 Last updated: Sep 12, 2016 Started: Apr 30, 2006 Primary completion: Jun 30, 2008 Completion: Jun 30, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Lack of efficacy

Other terminated trials from Takeda

See all terminations from Takeda

Other Papillomavirus Infections trials with similar outcome

NCT00117884 · Phase PHASE2 · Jun 2008

Browse all Papillomavirus Infections trials

A PHASE2 clinical study on Papillomavirus Infections, this trial is terminated or withdrawn. The trial is conducted by Takeda and has accumulated 8 data snapshots since 2006. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Terminated PHASE2
Sep 2024 — Sep 2025 [monthly]

Terminated PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE2
Apr 2022 — Jul 2024 [monthly]

Terminated PHASE2
Jan 2021 — Apr 2022 [monthly]

Terminated PHASE2

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Terminated PHASE2
Feb 2017 — Jun 2018 [monthly]

Terminated PHASE2
Jan 2017 — Feb 2017 [monthly]

Terminated PHASE2

First recorded

Apr 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Takeda

Data source: Takeda

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Albuquerque, United States , Atlanta, United States , Augusta, United States , Austin, United States , Aventura, United States , Birmingham, United States , Bismarck, United States , Boise, United States , Boynton Beach, United States , Bristol, United States and 82 more locations